NCT00385541View on ClinicalTrials.gov

Comparison of Side Effects of Morphine and Hydromorphone Patient-Controlled Analgesia (PCA)

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Post Operative Pain
Interventions
DRUG

Morphine PCA

Morphine 1mg/mL, dose 1mL, lockout 6 minutes, max 10mL

DRUG

Hydromorphone PCA

hydromorphone PCA 0.2mg/lml, dose 1ml, lockout 6min, max 10ml

Trial Locations (1)

10032

Columbia Presbyterian Hospital, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT00385541 - Comparison of Side Effects of Morphine and Hydromorphone Patient-Controlled Analgesia (PCA) | Biotech Hunter | Biotech Hunter